02Apr/13

Patent Controversy Resumes as Indian Supreme Court Rejects Novartis' Glivec … – Knowledge Wharton Today


Knowledge Wharton Today

Patent Controversy Resumes as Indian Supreme Court Rejects Novartis’ Glivec
Knowledge Wharton Today
wars that have been fought in India over the past few years. By and large, multinationals have been losing out — for example, Hyderabad-based firm Natco Pharma was granted a compulsory license for Bayer’s liver and kidney anti-cancer drug Nexavar.
Why the rejection of Novartis patent plea is a huge victory for IndiaFirstpost
India court ruling could deprive developing nations of patented drugsRaw Story
Patent problemsBusiness Standard
Economic Times
all 458 news articles »
01Apr/13

Himalaya, India's Booming Herbal Healthcare Company – Sudan Vision


Sudan Vision

Himalaya, India’s Booming Herbal Healthcare Company
Sudan Vision
“It’s high time people took us very seriously and did not view us as an alternative form of medicine,” says Philipe Haydon, the India chief executive of the Himalaya group from his office in tech and healthcare hub Bangalore. “This is not a feel-good
Not alternative medicine: Himalaya drug firm booms with herbal remediesChina Post

all 2 news articles »